EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)

Sejal Sharma iD, Yong Zhang, Khondker Ayesha Akter, Saeideh Nozohouri, Sabrina Rahman Archie, Dhavalkumar Patel iD, Heidi Villalba, Thomas Abbruscato

Pharmaceutics · 28.04.2023 · 15 (5) · 1357

DOI: 10.3390/pharmaceutics15051357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 28.04.2023. Verfasst von Sejal Sharma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our lab previously established that metformin, a first-line type two diabetes treatment, activates the Nrf2 pathway and improves post-stroke recovery. Metformin’s brain permeability value and potential interaction with blood–brain barrier (BBB) uptake and efflux transporters are currently unknown. Metformin has been shown to be a substrate of organic cationic transporters (Octs) in the liver and kidneys. Brain endothelial cells at the BBB have been shown to express Octs; thus, we hypothesize that metformin uses Octs for its transport across the BBB. We used a co-culture model of brain endothelial cells and primary astrocytes as an in vitro BBB model to conduct permeability studies during normoxia and hypoxia using oxygen–glucose deprivation (OGD) conditions. Metformin was quantified using a highly sensitive LC-MS/MS method. We further checked Octs protein expression using Western blot analysis. Lastly, we completed a plasma glycoprotein (P-GP) efflux assay. Our results showed that metformin is a highly permeable molecule, uses Oct1 for its transport, and does not interact with P-GP. During OGD, we found alterations in Oct1 expression and increased permeability for metformin. Additionally, we showed that selective transport is a key determinant of metformin’s permeability during OGD, thus, providing a novel target for improving ischemic drug delivery.

Schlagwörter

Stichwörter der Autor:innen

BBBOctsP-GPco-culturein vitroischemic strokemetforminpermeabilityrepurposingtransporters

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
  • Center for Blood-Brain Barrier Research, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.

ORCID-Profile: Sejal Sharma, Dhavalkumar Patel

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Sharma, S., Zhang, Y., Akter, K. A., Nozohouri, S., Archie, S. R., Patel, D., Villalba, H., & Abbruscato, T. (2023). Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs). Pharmaceutics, 15(5), 1357. https://doi.org/10.3390/pharmaceutics15051357

Vancouver

Sharma S, Zhang Y, Akter KA, Nozohouri S, Archie SR, Patel D, et al. Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs). Pharmaceutics. 2023;15(5):1357. doi:10.3390/pharmaceutics15051357

BibTeX
@article{Sharma2023,
  author = {Sharma, Sejal and Zhang, Yong and Akter, Khondker Ayesha and Nozohouri, Saeideh and Archie, Sabrina Rahman and Patel, Dhavalkumar and Villalba, Heidi and Abbruscato, Thomas},
  title = {Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1357},
  doi = {10.3390/pharmaceutics15051357}
}
Kostenlos starten →